|
Mood Effects of Serotonin Agonists: Depression
RECRUITINGEarly 1Sponsored by University of Chicago
Actively Recruiting
PhaseEarly 1
SponsorUniversity of Chicago
Started2025-06-09
Est. completion2026-06-01
Eligibility
Age18 Years – 40 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT07017478
Summary
This study will examine the effect of a low dose of the 5HT2A agonist LSD (26 µg), compared to placebo, on acute and protracted mood states in individuals with depression. The investigators will assess the relationship between mood-related symptoms and EEG as a neurophysiological marker.
Eligibility
Age: 18 Years – 40 YearsHealthy volunteers accepted
Inclusion Criteria: * English Fluency * high school education or higher * BMI between 19-30 kg/m2 Exclusion Criteria: * individuals with a medical condition contraindicating study participation as determined by the study physician (e.g., liver disease, abnormal EKG, liver or cardiovascular disease) * high blood pressure (\>140/90) * current suicidal ideation or suicide attempt in past 12 months * past year severe substance use disorder * personal or first-degree relative with history of psychosis * currently taking any psychiatric medication (for conventional antidepressants must be off for ≥ 2 weeks) * active panic disorder * severe obsessive-compulsive disorder * severe post-traumatic stress disorder * women who are pregnant or planning to become pregnant
Conditions3
DepressionLSDMajor Depressive Disorder
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseEarly 1
SponsorUniversity of Chicago
Started2025-06-09
Est. completion2026-06-01
Eligibility
Age18 Years – 40 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT07017478